Abstract
Background: Primary tracheal adenoid cystic carcinoma is a rare, slow-growing pulmonary malignancy. Due to the low incidence, clinicians are unable to diagnose and treat such disease, which is prone to cause misdiagnosis or missed diagnosis, consequently leading to delayed treatment.
Case Presentation: Here, we reported a case of a 72-year-old woman who was diagnosed as primary bronchial adenoid cystic carcinoma after three years. At the time of the final diagnosis, lesion involvement was seen in the entire bronchus, and radical treatment was not available.
Conclusions: Endoscopic bronchoscopy and palliative radiotherapy can relieve the symptoms of the patient and make the patient survive with the tumor for a long time.
Keywords: Tracheal adenoid cystic carcinoma, pulmonary malignancy, tumor, survive, cough, radiotherapy.
Graphical Abstract
Current Bioinformatics
Title:Continual Cough: Experience and Lessons from a Case of Bronchial Adenoid Cystic Carcinoma
Volume: 16 Issue: 4
Author(s): Lin Sheng, Junwei Tu, Yijun Sheng, Jingqian Zhu, Huijun Chen, Jianghua Tian, Lixia Wang and Chuli Pan*
Affiliation:
- Department of Respiratory Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang,China
Keywords: Tracheal adenoid cystic carcinoma, pulmonary malignancy, tumor, survive, cough, radiotherapy.
Abstract:
Background: Primary tracheal adenoid cystic carcinoma is a rare, slow-growing pulmonary malignancy. Due to the low incidence, clinicians are unable to diagnose and treat such disease, which is prone to cause misdiagnosis or missed diagnosis, consequently leading to delayed treatment.
Case Presentation: Here, we reported a case of a 72-year-old woman who was diagnosed as primary bronchial adenoid cystic carcinoma after three years. At the time of the final diagnosis, lesion involvement was seen in the entire bronchus, and radical treatment was not available.
Conclusions: Endoscopic bronchoscopy and palliative radiotherapy can relieve the symptoms of the patient and make the patient survive with the tumor for a long time.
Export Options
About this article
Cite this article as:
Sheng Lin , Tu Junwei , Sheng Yijun , Zhu Jingqian , Chen Huijun , Tian Jianghua , Wang Lixia and Pan Chuli *, Continual Cough: Experience and Lessons from a Case of Bronchial Adenoid Cystic Carcinoma, Current Bioinformatics 2021; 16 (4) . https://dx.doi.org/10.2174/1574893615666200831170923
DOI https://dx.doi.org/10.2174/1574893615666200831170923 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interaction of Human Brain Acetylcholinesterase with Cyclophosphamide: A Molecular Modeling and Docking Study
CNS & Neurological Disorders - Drug Targets Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Current Protein & Peptide Science Anticancer Potential of Ginger: Mechanistic and Pharmaceutical Aspects
Current Pharmaceutical Design Therapeutic Potential of Peptide Toxins that Target Ion Channels
Inflammation & Allergy - Drug Targets (Discontinued) Current Biomarkers for Lung Cancer
Current Signal Transduction Therapy Interplay Between JSRV, an Oncogenic Retrovirus, and the Pulmonary Epithelium
Current Immunology Reviews (Discontinued) Nutlins and Ionizing Radiation in Cancer Therapy
Current Pharmaceutical Design Erlotinib in Glioblastoma - Lost in Translation?
Anti-Cancer Agents in Medicinal Chemistry Which Dose of Folic Acid Should Pregnant Diabetic Women Receive?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development
Current Medicinal Chemistry Intracellular Drug Delivery: Mechanisms for Cell Entry
Current Pharmaceutical Design Pharmacogenomics of Non-Small Cell Lung Cancer
Current Pharmacogenomics Natural Products: Potential for Developing Phellodendron amurense Bark Extract for Prostate Cancer Management
Mini-Reviews in Medicinal Chemistry Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics
Current Drug Targets Novel N-mustard-benzimidazoles/benzothiazoles Hybrids, Synthesis and Anticancer Evaluation
Anti-Cancer Agents in Medicinal Chemistry Antioxidant Food Supplements and Obesity-Related Inflammation
Current Medicinal Chemistry Cancer Chemoprevention Drug Targets
Current Drug Targets Biological Function and Medicinal Research Significance of G-Quadruplex Interactive Proteins
Current Topics in Medicinal Chemistry MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer
Recent Patents on Biomarkers Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery